Clinical investigationIntermittent inotropic therapy in an outpatient setting: A cost-effective therapeutic modality in patients with refractory heart failure
References (19)
- et al.
Epidemiology in heart failure
Am Heart J
(1991) - et al.
Short-term use of intravenous milrinone for heart failure
Am J Cardiol
(1995) - et al.
The hemodynamic and metabolic advantages gained by a three-day infusion of dobutamine in patients with congestive cardiomyopathy
Am Heart J
(1983) - et al.
The natural history of congestive heart failure: the Framingham study
(1991) Success with heart failure
- et al.
The cardiovascular effects of the continous infusion of dobutamine in patients with severe cardiac failure
Circulation
(1991) - et al.
The role of intermittent inotropic therapy in the heart failure clinic of Michael Reese Hospital and Medical Center
Congestive Heart Failure
(1995)
There are more references available in the full text version of this article.
Cited by (86)
Meta-analysis Comparing the Efficacy of Dobutamine Versus Milrinone in Acute Decompensated Heart Failure and Cardiogenic Shock
2023, Current Problems in CardiologyHome Milrinone in Pediatric Hospice Care of Children with Heart Failure
2023, Journal of Pain and Symptom ManagementLong-Term Ambulatory Intravenous Milrinone Therapy in Advanced Heart Failure
2022, Heart Lung and CirculationEconomic analysis of intermittent intravenous outpatient treatment with levosimendan in advanced heart failure in Spain
2020, Revista Espanola de CardiologiaInfections, arrhythmias, and hospitalizations on home intravenous inotropic therapy
2016, American Journal of CardiologyPDE3 inhibition in dilated cardiomyopathy
2011, Current Opinion in PharmacologyCitation Excerpt :Another situation involves chronic intermittent outpatient infusion of milrinone. In nonrandomized trials with a limited number of subjects, patients treated with milrinone had significant functional improvement, a reduced number of emergency room visits and hospital admissions, and a marked reduction in hospitalization days, without evidence of increased mortality [56,57]. In other studies, patients treated with intermittent infusions of inotropic agents while receiving continuous treatment with antiarrhythmic drugs had largely favorable outcomes [58,59].
Copyright © 1996 Published by Mosby, Inc.